APA (7th ed.) Citation

Xu, Y. (2022). PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR. https://doi.org/10.5282/edoc.30741

Chicago Style (17th ed.) Citation

Xu, Yinhui. PD-L1 Enhanced Cisplatin Resistance in Non-small Cell Lung Cancer Through PI3K/AKT/mTOR. München, 2022. https://doi.org/10.5282/edoc.30741.

MLA (9th ed.) Citation

Xu, Yinhui. PD-L1 Enhanced Cisplatin Resistance in Non-small Cell Lung Cancer Through PI3K/AKT/mTOR. 2022. https://doi.org/10.5282/edoc.30741.